OSRH acquires WORIO for $10.6M in stock; non-invasive glucose monitoring tech

OSR Holdings, Inc.

OSRH subsidiary OSRK to acquire WORIO via share exchange for KRW 15B (~USD 10.6M). WORIO becomes indirect wholly owned subsidiary.
WORIO develops needle-free continuous glucose monitor using NIRS technology; has an active partnership with Samsung for clinical trials with non-dilutive funding.
Each WORIO share exchanged for 0.948832 OSRK shares; OSRK issues 84,338 new shares for 88,891 WORIO shares.
If OSRH stock reaches $10 within 3 years, OSRK shares may convert into OSRH common at 12.96:1 ratio, up to ~1.09M new shares.
Closing expected Jan 12, 2026, subject to WORIO shareholder vote (Dec 19, 2025) and regulatory clearances.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.